Cargando…

Baricitinib as the treatment of choice for hospitalised individuals with COVID-19

Detalles Bibliográficos
Autores principales:	Richardson, Peter J., Stebbing, Justin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9165526/ https://www.ncbi.nlm.nih.gov/pubmed/35692219 http://dx.doi.org/10.1016/j.eclinm.2022.101493

Ejemplares similares

Baricitinib: the first immunomodulatory treatment to reduce COVID-19 mortality in a placebo-controlled trial
por: Kalil, Andre C, et al.
Publicado: (2021)

Baricitinib for COVID-19: a suitable treatment? – Authors' reply
por: Richardson, Peter J, et al.
Publicado: (2020)

The AI-Assisted Identification and Clinical Efficacy of Baricitinib in the Treatment of COVID-19
por: Richardson, Peter J., et al.
Publicado: (2022)

COVID-19: combining antiviral and anti-inflammatory treatments
por: Stebbing, Justin, et al.
Publicado: (2020)

Baricitinib for patients with severe COVID-19—time to change the standard of care?
por: Supady, Alexander, et al.
Publicado: (2022)

Baricitinib in COVID-19: a coming-of-age from artificial intelligence to reducing mortality
por: Mehta, Puja, et al.
Publicado: (2022)

Lessons to Europe from China for cancer treatment during the COVID-19 pandemic
por: Peng, Ling, et al.
Publicado: (2020)

Monoclonals for patients hospitalised with COVID-19
por: Pogue, Jason M, et al.
Publicado: (2022)

Developments in paediatric cancer care throughout the COVID-19 pandemic: Lessons from China
por: Boiardi, Federico, et al.
Publicado: (2022)

COVID-19 and involuntary hospitalisation: navigating the challenge
por: Gold, Azgad, et al.
Publicado: (2020)

Convalescent plasma in patients hospitalised with COVID-19
por: Liu, Sean T H, et al.
Publicado: (2021)

Hospitalisation among vaccine breakthrough COVID-19 infections
por: Juthani, Prerak V, et al.
Publicado: (2021)

Antiviral monotherapy for hospitalised patients with COVID-19 is not enough
por: Cao, Bin, et al.
Publicado: (2020)

Dexamethasone in hospitalised patients with COVID-19: addressing uncertainties
por: Matthay, Michael A, et al.
Publicado: (2020)

Baricitinib as potential treatment for 2019-nCoV acute respiratory disease
por: Richardson, Peter, et al.
Publicado: (2020)

Early oral antiviral use in patients hospitalised with COVID-19
por: Zarębska-Michaluk, Dorota, et al.
Publicado: (2022)

COVID-19 outbreak and decreased hospitalisation of pregnant women in labour
por: Kumari, Vimla, et al.
Publicado: (2020)

Renin-angiotensin system inhibitors in hospitalised patients with COVID-19
por: Williams, Bryan
Publicado: (2021)

High-dose immunoglobulins from convalescent donors for patients hospitalised with COVID-19
por: So-Osman, Cynthia, et al.
Publicado: (2022)

Time to knock monoclonal antibodies off the platform for patients hospitalised with COVID-19
por: Shapiro, Adrienne E, et al.
Publicado: (2022)

Alternatives to conventional hospitalisation that enhance health systems' capacity to treat COVID-19
por: Nicolás, David, et al.
Publicado: (2021)

Baricitinib in hospitalised patients with COVID-19: A meta-analysis of randomised controlled trials
por: Selvaraj, Vijairam, et al.
Publicado: (2022)

Baricitinib + SOC cost effective vs SOC for patients hospitalised with COVID-19 in the USA
Publicado: (2021)

Baricitinib + remdesivir cost saving vs remdesivir for hospitalised COVID-19 patients in the USA
Publicado: (2021)

Effectiveness of the COVID-19 vaccines against hospitalisation with Omicron sub-lineages BA.4 and BA.5 in England
por: Møller Kirsebom, Freja Cordelia, et al.
Publicado: (2022)

Predicted COVID-19 positive cases, hospitalisations, and deaths associated with the Delta variant of concern, June–July, 2021
por: Shah, Syed Ahmar, et al.
Publicado: (2021)

Mechanism of baricitinib supports artificial intelligence‐predicted testing in COVID‐19 patients
por: Stebbing, Justin, et al.
Publicado: (2020)

From choice architecture to choice engineering
por: Dan, Ohad, et al.
Publicado: (2019)

COVID-19 related stroke in young individuals
por: Fifi, Johanna T, et al.
Publicado: (2020)

The incidence of Coronavirus disease 2019 (COVID-19) among vaccinated healthcare workers (HCWs): evidence for protection from hospitalisation from an Indonesian cohort
por: Kozlakidis, Zisis
Publicado: (2023)

Baricitinib for COVID-19: a suitable treatment?
por: Favalli, Ennio G, et al.
Publicado: (2020)

Expert-Augmented Computational Drug Repurposing Identified Baricitinib as a Treatment for COVID-19
por: Smith, Daniel P., et al.
Publicado: (2021)

Case isolation, contact tracing, and physical distancing are pillars of COVID-19 pandemic control, not optional choices
por: MacIntyre, Chandini Raina
Publicado: (2020)

Vaccination prevents hospitalisations of children and adolescents. A real-world analysis
por: Bolcatto, Pablo G.
Publicado: (2022)

SARS-CoV-2 spread and hospitalisations in paediatric patients during the omicron surge
por: Belay, Ermias D, et al.
Publicado: (2022)

Waning of COVID-19 vaccine effectiveness: individual and public health risk
por: Piechotta, Vanessa, et al.
Publicado: (2022)

Risk, responsibility, and choice in research ethics
por: Cook, Elizabeth, et al.
Publicado: (2022)

A choice between two futures for pandemic recovery
por: Carlson, Colin J, et al.
Publicado: (2020)

Mixing mRNA, adenoviral, and spike-adjuvant vaccines for protection against COVID-19
por: Richardson, Christopher D
Publicado: (2022)

Extending the interval of COVID-19 vaccine regimens in individuals aged 80 years or older
por: Iversen, Patrick L, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_q3hq5cclmnp82nhmuqfc1qhfvi